Loading…
M Six Labs, Inc. was found to be selling unapproved new drugs in violation of federal law, including multiple CBD and Delta-8 THC products for humans (such as tinctures, balms, gummies, and edibles) and CBD-containing products for animals marketed without FDA approval. The company's products were determined to be misbranded under the Federal Food, Drug, and Cosmetic Act and lacked required drug approvals before being introduced into interstate commerce through their website. Additionally, the animal CBD products were found to be unsafe and adulterated, as they had not undergone the required approval process for new animal drugs.